Statistics
Player Statistics
Every FPL player — points, price, form, ownership and upcoming fixtures. Filter by team and position.
Name | Fixtures | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| £5.5m | 49.8% | 75 | 4.0 | 13.6 | 0 | 2 | 4 | 8,428 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £15.8m | 78.6% | 72 | 3.5 | 4.6 | 2 | 9 | 0 | -25,520 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.3m | 49.4% | 70 | 3.0 | 11.1 | 0 | 4 | 6 | 7,739 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.3m | 11.4% | 70 | 4.8 | 13.2 | 0 | 1 | 2 | 8,491 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £8.1m | 26.6% | 67 | 8.0 | 8.3 | 1 | 1 | 0 | 4,779 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.5m | 26.3% | 67 | 7.5 | 10.3 | 6 | 6 | 4 | 33,242 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £6.7m | 32.7% | 66 | 6.0 | 9.9 | 8 | 5 | 1 | 21,012 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.1m | 18.3% | 63 | 8.0 | 12.4 | 6 | 2 | 0 | 17,395 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.8m | 11.4% | 62 | 4.2 | 12.9 | 4 | 2 | 1 | 8,553 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £6.3m | 47.7% | 61 | 4.8 | 9.7 | 1 | 0 | 0 | -8,264 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £9.3m | 26.3% | 61 | 4.8 | 6.6 | 0 | 7 | 0 | 14,671 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.9m | 48.6% | 58 | 3.5 | 9.8 | 1 | 1 | 2 | -1,262 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.9m | 25.5% | 58 | 8.2 | 11.8 | 1 | 1 | 0 | 1,708 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.1m | 6.8% | 58 | 6.0 | 11.4 | 2 | 0 | 2 | 10,638 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.7m | 24.3% | 57 | 4.8 | 12.1 | 0 | 0 | 0 | 4,395 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £8.2m | 54.6% | 57 | 4.2 | 7.0 | 5 | 5 | 2 | 7,701 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £7.2m | 35.9% | 56 | 8.8 | 7.8 | 2 | 6 | 1 | 20,238 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.6m | 3.5% | 56 | 8.8 | 10.0 | 14 | 0 | 1 | 9,276 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £6.2m | 18.8% | 56 | 2.5 | 9.0 | 0 | 1 | 1 | -2,859 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 6.8% | 56 | 6.0 | 11.2 | 2 | 0 | 0 | 10,379 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £6.7m | 16.6% | 55 | 5.5 | 8.2 | 5 | 3 | 1 | 2,070 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.7m | 11.5% | 55 | 6.8 | 9.6 | 0 | 6 | 1 | 1,440 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.5m | 2.5% | 55 | 5.2 | 12.2 | 4 | 1 | 0 | 2,109 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £7.9m | 33.4% | 55 | 2.8 | 7.0 | 1 | 5 | 2 | -36,397 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £7.5m | 13.7% | 51 | 3.8 | 6.8 | 1 | 0 | 5 | 1,633 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.1m | 4.7% | 51 | 3.5 | 10.0 | 0 | 2 | 3 | 1,759 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £6.0m | 5.6% | 51 | 4.8 | 8.5 | 7 | 3 | 3 | -2,075 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £6.7m | 7.2% | 50 | 3.8 | 7.5 | 0 | 3 | 1 | 676 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £9.8m | 28.0% | 49 | 2.8 | 5.0 | 2 | 3 | 4 | -10,242 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.9m | 1.6% | 49 | 5.8 | 10.0 | 10 | 3 | 2 | 6,453 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.7m | 13.3% | 49 | 2.5 | 10.4 | 0 | 0 | 0 | -1,067 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.7m | 3.1% | 49 | 6.2 | 8.6 | 3 | 3 | 1 | 1,576 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.1m | 3.9% | 48 | 6.8 | 9.4 | 8 | 0 | 0 | 2,475 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.3m | 8.8% | 48 | 2.2 | 9.1 | 0 | 3 | 3 | -3,767 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £6.0m | 16.5% | 48 | 3.8 | 8.0 | 9 | 4 | 2 | 14,207 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.8m | 9.3% | 47 | 1.5 | 8.1 | 0 | 3 | 4 | -5,538 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £7.6m | 28.5% | 47 | 0.0 | 6.2 | 0 | 5 | 3 | -23,458 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.2m | 16.9% | 47 | 3.0 | 9.0 | 1 | 1 | 1 | -4,924 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 15.9% | 47 | 6.0 | 10.7 | 7 | 0 | 0 | 3,395 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.1m | 12.1% | 46 | 1.5 | 7.5 | 0 | 3 | 2 | -6,290 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.5m | 2.5% | 46 | 3.8 | 8.4 | 0 | 3 | 1 | -181 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £7.3m | 7.0% | 46 | 5.2 | 6.3 | 0 | 1 | 5 | 10,081 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £7.8m | 17.9% | 46 | 1.2 | 5.9 | 0 | 4 | 1 | 442 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.5m | 4.9% | 45 | 4.2 | 8.2 | 1 | 2 | 4 | 1,924 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.6m | 20.2% | 45 | 1.0 | 8.0 | 1 | 1 | 4 | -28,353 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £11.6m | 20.0% | 45 | 3.0 | 3.9 | 0 | 4 | 2 | 2,298 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £7.8m | 5.6% | 45 | 2.0 | 5.8 | 0 | 1 | 4 | 1,696 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.5m | 0.7% | 44 | 2.5 | 9.8 | 0 | 0 | 1 | 116 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 1.2% | 44 | 4.0 | 9.8 | 0 | 0 | 2 | -320 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.1m | 4.8% | 44 | 3.5 | 8.6 | 0 | 0 | 0 | 888 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.5m | 4.8% | 44 | 5.2 | 8.0 | 0 | 0 | 0 | 2,538 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.8m | 2.0% | 44 | 7.5 | 9.2 | 11 | 0 | 0 | 524 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.5m | 2.2% | 43 | 3.0 | 7.8 | 0 | 0 | 0 | -112 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.7m | 0.5% | 43 | 5.2 | 7.5 | 15 | 4 | 0 | 20,662 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £6.4m | 14.4% | 43 | 3.5 | 6.7 | 0 | 0 | 0 | 850 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.4m | 4.0% | 42 | 2.5 | 7.8 | 0 | 0 | 3 | -2,397 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.5m | 3.9% | 42 | 3.0 | 9.3 | 0 | 1 | 0 | -735 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £6.6m | 4.8% | 42 | 2.0 | 6.4 | 1 | 3 | 1 | -5,351 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.6m | 2.5% | 42 | 3.5 | 9.1 | 0 | 0 | 1 | -338 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.2m | 11.7% | 42 | 3.0 | 10.0 | 0 | 1 | 0 | -1,856 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.5m | 4.1% | 42 | 3.0 | 7.6 | 0 | 0 | 0 | 834 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £6.2m | 8.8% | 41 | 2.8 | 6.6 | 1 | 2 | 3 | 2,558 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 1.5% | 41 | 3.0 | 9.1 | 0 | 1 | 0 | 40 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 4.3% | 41 | 3.8 | 9.1 | 2 | 0 | 0 | -413 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.4m | 1.4% | 41 | 3.0 | 7.6 | 1 | 1 | 1 | -648 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.5m | 0.5% | 41 | 5.5 | 7.5 | 6 | 1 | 1 | 886 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.4m | 2.8% | 41 | 3.2 | 7.6 | 2 | 2 | 1 | -1,475 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £7.8m | 8.9% | 41 | 2.8 | 5.3 | 2 | 1 | 3 | -1,830 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £7.4m | 5.8% | 40 | 4.2 | 5.4 | 5 | 3 | 1 | -420 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.9m | 1.0% | 40 | 6.0 | 6.8 | 9 | 2 | 2 | 4,316 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.5m | 0.3% | 40 | 3.8 | 7.3 | 12 | 2 | 3 | 317 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.5m | 1.1% | 40 | 5.2 | 7.3 | 2 | 2 | 2 | -256 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £7.1m | 7.0% | 40 | 2.0 | 5.6 | 0 | 1 | 3 | -232 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.4m | 3.4% | 39 | 6.0 | 7.2 | 6 | 0 | 1 | 538 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.5m | 1.7% | 39 | 1.5 | 7.1 | 0 | 2 | 1 | -752 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.5m | 8.4% | 39 | 2.8 | 7.1 | 0 | 0 | 0 | -372 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.8m | 5.3% | 39 | 2.8 | 6.7 | 2 | 0 | 4 | -4,136 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.9m | 12.5% | 39 | 0.5 | 6.6 | 2 | 1 | 1 | -5,180 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.2m | 3.5% | 39 | 4.2 | 6.3 | 10 | 1 | 1 | 1,783 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.3m | 2.9% | 39 | 4.2 | 9.1 | 1 | 0 | 2 | -1,113 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.6% | 38 | 2.0 | 7.6 | 2 | 1 | 3 | -288 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.1m | 6.4% | 38 | 1.8 | 9.3 | 0 | 0 | 0 | -1,799 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.5m | 1.7% | 38 | 5.5 | 6.9 | 0 | 2 | 3 | -125 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.3m | 0.7% | 38 | 3.8 | 7.2 | 7 | 0 | 2 | 103 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £9.4m | 5.2% | 37 | 0.0 | 3.9 | 0 | 3 | 0 | -1,807 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.0m | 0.4% | 37 | 3.2 | 7.4 | 3 | 0 | 1 | -52 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.1m | 3.4% | 37 | 2.8 | 7.3 | 6 | 0 | 0 | 3,359 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.0m | 1.6% | 37 | 1.8 | 7.4 | 0 | 2 | 0 | -415 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 1.2% | 37 | 3.0 | 8.2 | 1 | 0 | 1 | -102 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £8.2m | 5.3% | 37 | 0.0 | 4.5 | 0 | 2 | 3 | -1,891 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.3m | 1.4% | 37 | 4.5 | 7.0 | 8 | 0 | 0 | 40 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 3.3% | 36 | 5.2 | 8.0 | 6 | 0 | 0 | 539 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.5m | 0.5% | 36 | 3.8 | 8.0 | 4 | 0 | 0 | 290 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.0m | 5.8% | 35 | 2.8 | 7.0 | 0 | 0 | 0 | -582 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.0m | 6.9% | 35 | 1.0 | 8.8 | 3 | 0 | 0 | -1,069 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.4m | 2.7% | 35 | 1.2 | 6.5 | 1 | 2 | 1 | -1,475 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.4m | 7.0% | 35 | 1.5 | 6.5 | 2 | 0 | 0 | -3,471 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.0m | 0.4% | 35 | 2.8 | 7.0 | 5 | 2 | 1 | -178 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.9m | 4.9% | 35 | 3.0 | 7.1 | 1 | 1 | 1 | -1,862 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.5m | 2.0% | 35 | 2.0 | 6.4 | 0 | 0 | 1 | -384 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.5m | 6.4% | 34 | 2.5 | 7.6 | 0 | 1 | 0 | -1,189 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 4.5% | 34 | 1.5 | 7.7 | 1 | 2 | 0 | -1,613 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.1m | 4.4% | 34 | 1.5 | 8.3 | 0 | 1 | 0 | -605 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £6.0m | 1.6% | 34 | 0.8 | 5.7 | 1 | 1 | 0 | -293 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.3m | 1.9% | 34 | 2.2 | 6.4 | 0 | 0 | 1 | -1,881 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.3m | 2.5% | 33 | 4.5 | 5.2 | 3 | 1 | 0 | -181 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.9m | 0.4% | 33 | 3.0 | 5.6 | 10 | 2 | 2 | 410 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.4m | 1.2% | 33 | 3.5 | 7.5 | 1 | 0 | 0 | -248 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.3m | 2.3% | 33 | 2.0 | 6.2 | 0 | 0 | 1 | -2,838 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.4m | 5.6% | 32 | 2.0 | 5.9 | 0 | 0 | 2 | -1,608 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.0m | 0.1% | 32 | 3.2 | 6.4 | 1 | 0 | 1 | -35 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.2m | 1.6% | 32 | 4.5 | 7.6 | 5 | 0 | 0 | -153 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.7m | 4.1% | 32 | 2.0 | 5.6 | 0 | 3 | 1 | -5,531 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.6% | 31 | 5.5 | 6.3 | 3 | 2 | 2 | 1,379 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 0.1% | 31 | 3.5 | 6.9 | 3 | 0 | 0 | 8 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 2.4% | 31 | 1.0 | 7.8 | 0 | 0 | 1 | -774 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 2.7% | 31 | 1.8 | 7.8 | 3 | 1 | 0 | -448 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.6m | 1.1% | 31 | 1.8 | 5.5 | 0 | 1 | 1 | -114 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.0m | 1.1% | 31 | 3.8 | 6.2 | 1 | 0 | 0 | -304 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.3m | 1.7% | 31 | 4.5 | 5.8 | 1 | 3 | 0 | 247 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.5m | 0.1% | 31 | 3.2 | 5.6 | 4 | 0 | 0 | -21 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.0m | 4.0% | 31 | 3.0 | 6.2 | 0 | 0 | 0 | -1,361 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.2m | 0.6% | 30 | 5.2 | 4.8 | 8 | 2 | 1 | 838 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.7m | 2.1% | 30 | 2.2 | 4.5 | 2 | 2 | 0 | -699 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.9m | 1.0% | 30 | 0.5 | 5.1 | 1 | 1 | 1 | -428 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.9m | 2.1% | 30 | 0.0 | 5.1 | 0 | 1 | 2 | -21 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £7.8m | 6.7% | 30 | 3.0 | 3.8 | 0 | 2 | 3 | -6,407 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.0m | 1.4% | 30 | 1.2 | 7.5 | 0 | 1 | 1 | -401 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.9m | 0.5% | 30 | 2.5 | 6.1 | 3 | 0 | 0 | -54 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.3m | 0.6% | 30 | 2.2 | 5.7 | 1 | 0 | 1 | -121 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.5m | 0.5% | 30 | 2.2 | 5.5 | 0 | 1 | 1 | -146 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.1% | 30 | 3.5 | 6.0 | 3 | 0 | 0 | 5 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.1% | 30 | 3.5 | 6.7 | 4 | 0 | 0 | 54 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.5m | 2.0% | 30 | 1.5 | 5.5 | 2 | 0 | 0 | -707 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.5m | 1.1% | 30 | 1.0 | 5.5 | 0 | 0 | 1 | 29 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.5m | 0.5% | 30 | 1.2 | 5.5 | 1 | 2 | 0 | -235 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £6.6m | 2.5% | 30 | 3.5 | 4.5 | 2 | 0 | 3 | -861 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.2% | 29 | 4.8 | 6.4 | 6 | 0 | 0 | 144 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.0m | 0.3% | 29 | 3.2 | 5.8 | 3 | 0 | 0 | -18 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.3m | 1.2% | 29 | 0.2 | 6.7 | 0 | 0 | 0 | -197 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.9m | 1.3% | 29 | 1.5 | 5.9 | 2 | 2 | 1 | -766 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.8m | 0.3% | 29 | 2.8 | 6.0 | 4 | 0 | 1 | 37 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 6.3% | 29 | 0.8 | 7.2 | 1 | 2 | 2 | -2,916 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.0m | 1.1% | 29 | 2.5 | 7.2 | 0 | 1 | 3 | -92 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.1% | 29 | 2.5 | 6.4 | 1 | 0 | 1 | 67 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.9m | 0.3% | 29 | 3.0 | 5.9 | 2 | 0 | 2 | -14 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £6.7m | 13.4% | 29 | 2.0 | 4.3 | 0 | 1 | 1 | 590 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.4m | 1.0% | 29 | 4.0 | 6.6 | 0 | 0 | 2 | -310 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.8m | 1.3% | 29 | 2.8 | 5.0 | 7 | 2 | 1 | -168 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.8% | 28 | 2.0 | 6.2 | 2 | 0 | 1 | -193 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.3% | 28 | 2.2 | 5.6 | 0 | 0 | 1 | -102 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.1% | 28 | 2.2 | 5.6 | 3 | 0 | 0 | -13 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.3m | 5.0% | 28 | 4.8 | 5.3 | 12 | 0 | 1 | 2,909 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.6m | 0.7% | 28 | 4.8 | 5.0 | 4 | 0 | 1 | -19 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.2% | 28 | 4.5 | 6.4 | 6 | 0 | 0 | -1 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.8m | 0.2% | 28 | 3.2 | 5.8 | 3 | 0 | 0 | -33 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.9m | 0.2% | 27 | 1.2 | 4.6 | 0 | 1 | 2 | -91 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.0m | 0.9% | 27 | 2.0 | 5.4 | 4 | 0 | 3 | -423 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.2m | 0.1% | 27 | 2.8 | 5.2 | 1 | 2 | 1 | -16 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.4m | 1.4% | 27 | 3.2 | 5.0 | 0 | 1 | 0 | 109 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £6.5m | 0.6% | 27 | 0.2 | 4.2 | 0 | 2 | 1 | -123 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £7.5m | 4.4% | 27 | 2.0 | 3.6 | 2 | 1 | 2 | -5,206 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.0m | 0.7% | 27 | 0.2 | 5.4 | 1 | 1 | 0 | -172 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 0.2% | 27 | 3.0 | 6.1 | 6 | 0 | 1 | -12 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.7% | 26 | 1.5 | 5.8 | 0 | 0 | 0 | -442 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £6.2m | 0.4% | 26 | 4.2 | 4.2 | 0 | 1 | 1 | 30 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 1.1% | 26 | 0.0 | 5.8 | 0 | 1 | 1 | -489 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.4m | 0.2% | 26 | 3.2 | 5.9 | 1 | 1 | 0 | 27 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £3.9m | 2.5% | 26 | 6.0 | 6.7 | 6 | 0 | 1 | 398 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.0m | 0.1% | 25 | 3.8 | 5.0 | 3 | 0 | 1 | 19 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.9m | 0.6% | 25 | 0.8 | 4.2 | 0 | 3 | 0 | -114 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.4m | 2.5% | 25 | 0.8 | 5.7 | 0 | 2 | 0 | -1,294 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.5% | 25 | 1.5 | 5.6 | 0 | 0 | 3 | -413 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.5% | 25 | 2.8 | 5.6 | 1 | 0 | 0 | -23 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £6.0m | 0.2% | 25 | 2.0 | 4.2 | 0 | 0 | 0 | -62 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.8m | 3.1% | 25 | 1.8 | 4.3 | 1 | 1 | 0 | -2,346 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 0.6% | 25 | 2.0 | 6.2 | 0 | 0 | 0 | -36 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.3m | 1.8% | 25 | 2.2 | 4.7 | 0 | 0 | 0 | -149 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £8.1m | 4.4% | 25 | 3.0 | 3.1 | 0 | 0 | 3 | 1,087 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.9m | 1.3% | 25 | 2.5 | 5.1 | 7 | 1 | 0 | -240 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.0m | 1.3% | 25 | 1.8 | 5.0 | 2 | 0 | 0 | -234 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £7.0m | 2.5% | 25 | 1.8 | 3.6 | 1 | 1 | 0 | -4,100 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.9m | 0.2% | 25 | 2.8 | 5.1 | 1 | 1 | 0 | -80 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.2% | 24 | 2.8 | 4.8 | 1 | 1 | 1 | -39 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.8m | 4.2% | 24 | 0.8 | 4.1 | 0 | 0 | 1 | -1,996 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.0m | 0.2% | 24 | 0.8 | 4.8 | 1 | 1 | 0 | -77 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.5m | 4.2% | 24 | 1.5 | 5.3 | 0 | 0 | 1 | -1,231 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £6.9m | 3.5% | 24 | 1.8 | 3.5 | 1 | 1 | 0 | -2,473 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.5m | 0.2% | 24 | 2.2 | 4.4 | 0 | 0 | 1 | -57 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.6m | 0.3% | 24 | 3.8 | 4.3 | 0 | 1 | 0 | -1,209 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.1m | 3.8% | 23 | 1.8 | 3.8 | 1 | 0 | 2 | -638 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.0m | 0.1% | 23 | 4.8 | 4.6 | 0 | 1 | 1 | 64 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £6.8m | 2.1% | 23 | 1.2 | 3.4 | 2 | 1 | 2 | -1,206 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.0m | 2.2% | 23 | 1.2 | 3.8 | 1 | 2 | 0 | -238 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.9m | 7.5% | 23 | 1.2 | 3.9 | 1 | 1 | 1 | -4,023 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.8m | 0.4% | 23 | 4.5 | 4.0 | 5 | 1 | 2 | 155 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.4% | 22 | 0.0 | 4.9 | 0 | 0 | 1 | -106 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.0m | 0.3% | 22 | 3.5 | 4.4 | 2 | 0 | 1 | 98 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.0m | 0.2% | 22 | 2.2 | 5.5 | 3 | 1 | 0 | -3 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.2% | 22 | 1.2 | 4.2 | 1 | 1 | 0 | -46 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.9m | 0.9% | 22 | 0.8 | 3.7 | 0 | 0 | 0 | -651 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.9m | 0.1% | 22 | 4.5 | 3.7 | 1 | 1 | 1 | 82 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.0m | 0.1% | 22 | 1.0 | 4.4 | 0 | 1 | 1 | -40 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.2% | 21 | 2.0 | 4.7 | 8 | 0 | 0 | 410 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 3.0% | 21 | 0.2 | 4.3 | 1 | 0 | 0 | 176 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £3.9m | 6.8% | 21 | 2.0 | 5.4 | 1 | 0 | 1 | -825 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.8m | 0.1% | 21 | 4.2 | 4.4 | 7 | 2 | 0 | 189 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.4m | 0.3% | 21 | 4.2 | 3.9 | 5 | 2 | 0 | 44 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.3% | 21 | 4.2 | 4.0 | 8 | 2 | 0 | 468 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £3.9m | 9.6% | 21 | 1.0 | 5.4 | 0 | 0 | 0 | -1,707 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.8m | 0.1% | 21 | 3.8 | 4.4 | 1 | 1 | 0 | -9 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.5% | 21 | 2.0 | 4.2 | 0 | 0 | 0 | -82 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 7.0% | 21 | 1.2 | 4.4 | 0 | 0 | 0 | -1,024 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.7m | 0.3% | 21 | 2.8 | 3.7 | 0 | 1 | 2 | -35 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.4m | 0.7% | 21 | 1.0 | 3.9 | 2 | 1 | 1 | -138 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.1% | 20 | 2.2 | 4.1 | 1 | 0 | 1 | -40 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.5m | 0.1% | 20 | 0.8 | 3.6 | 0 | 1 | 1 | -8 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.8m | 0.9% | 20 | 2.2 | 4.2 | 0 | 0 | 0 | -255 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.8m | 0.1% | 20 | 1.2 | 4.2 | 1 | 0 | 0 | -20 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.0% | 20 | 0.8 | 4.0 | 2 | 0 | 1 | -5 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.2m | 0.1% | 20 | 1.8 | 3.8 | 1 | 1 | 1 | -12 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.3m | 1.2% | 20 | 2.5 | 3.8 | 2 | 0 | 0 | -143 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.2m | 1.0% | 19 | 3.5 | 3.1 | 10 | 1 | 0 | 51 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.3m | 0.3% | 19 | 0.5 | 3.6 | 0 | 0 | 1 | -31 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 0.1% | 19 | 3.5 | 4.2 | 0 | 0 | 0 | 40 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.8m | 0.1% | 19 | 1.5 | 4.0 | 0 | 0 | 0 | -78 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.4% | 19 | 1.2 | 3.8 | 1 | 1 | 1 | -228 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.9m | 0.1% | 19 | 1.0 | 3.9 | 4 | 0 | 1 | 1 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.2m | 0.3% | 19 | 2.8 | 3.7 | 7 | 1 | 0 | -14 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.3m | 3.3% | 18 | 1.0 | 4.2 | 0 | 0 | 0 | -1,912 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 0.4% | 18 | 0.0 | 4.0 | 0 | 0 | 0 | -53 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.4m | 0.5% | 18 | 2.2 | 4.1 | 5 | 0 | 0 | 297 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.4m | 0.4% | 18 | 2.0 | 3.3 | 1 | 1 | 1 | -73 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.4m | 0.1% | 18 | 1.5 | 3.3 | 1 | 0 | 2 | -20 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.5m | 0.1% | 18 | 0.8 | 3.3 | 2 | 0 | 0 | 6 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.3m | 0.2% | 18 | 1.2 | 3.4 | 3 | 1 | 0 | -17 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.3% | 17 | 3.2 | 3.9 | 7 | 0 | 0 | 256 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £6.2m | 8.0% | 17 | 1.0 | 2.7 | 2 | 0 | 0 | -1,067 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.2m | 4.0% | 17 | 2.2 | 3.3 | 0 | 0 | 1 | -1,087 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.9m | 0.2% | 16 | 1.0 | 3.3 | 1 | 0 | 0 | -51 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.7m | 0.4% | 16 | 0.2 | 3.4 | 0 | 1 | 1 | -76 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.8m | 0.2% | 16 | 1.0 | 3.3 | 1 | 0 | 0 | -21 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.9m | 0.1% | 16 | 1.2 | 3.3 | 0 | 0 | 1 | -8 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.5m | 0.1% | 16 | 1.0 | 2.9 | 2 | 2 | 0 | -32 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £6.1m | 1.1% | 16 | 2.5 | 2.6 | 4 | 0 | 1 | -17 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.7m | 1.2% | 16 | 1.0 | 3.4 | 0 | 0 | 0 | -141 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.6m | 4.6% | 16 | 0.0 | 3.5 | 0 | 0 | 1 | -1,873 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.4m | 0.3% | 16 | 1.8 | 3.6 | 6 | 0 | 0 | 24 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.2m | 0.6% | 16 | 0.8 | 2.6 | 2 | 1 | 0 | -75 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £6.5m | 1.1% | 15 | 3.0 | 2.3 | 1 | 0 | 0 | 522 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.3m | 1.0% | 15 | 2.2 | 2.8 | 1 | 0 | 0 | -341 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.8m | 0.1% | 15 | 1.2 | 3.1 | 1 | 1 | 0 | -31 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.8m | 0.1% | 15 | 0.8 | 2.6 | 0 | 0 | 0 | -22 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.9m | 0.0% | 15 | 1.8 | 3.1 | 0 | 0 | 0 | -5 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.4m | 0.5% | 15 | 2.2 | 3.4 | 3 | 0 | 0 | 17 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.8m | 0.7% | 15 | 3.2 | 3.1 | 2 | 0 | 0 | 75 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.4m | 0.7% | 15 | 0.8 | 2.8 | 1 | 0 | 0 | -28 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.3m | 0.5% | 14 | 0.8 | 2.6 | 1 | 0 | 0 | -81 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.9m | 0.1% | 14 | 3.2 | 2.9 | 0 | 0 | 0 | 40 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.4m | 0.1% | 14 | 1.5 | 2.6 | 0 | 0 | 1 | -8 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.2m | 0.4% | 14 | 0.8 | 2.7 | 0 | 0 | 2 | -51 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.9m | 0.2% | 14 | 1.0 | 2.9 | 1 | 0 | 1 | -12 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.3m | 0.1% | 14 | 2.5 | 2.6 | 2 | 0 | 1 | 0 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.1% | 14 | 0.8 | 2.6 | 0 | 0 | 1 | -29 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.7m | 0.1% | 14 | 1.5 | 3.0 | 1 | 0 | 0 | 12 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.4m | 0.1% | 14 | 0.2 | 2.6 | 0 | 0 | 0 | -12 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.2% | 14 | 3.5 | 3.2 | 12 | 1 | 1 | 5,807 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.7m | 0.9% | 14 | 0.0 | 3.0 | 0 | 0 | 0 | -236 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.5m | 0.1% | 13 | 1.0 | 2.4 | 0 | 0 | 1 | -14 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.9m | 0.1% | 13 | 3.0 | 2.2 | 2 | 1 | 0 | 54 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.8m | 0.1% | 13 | 0.5 | 2.7 | 1 | 0 | 0 | -16 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.1% | 13 | 0.2 | 2.9 | 0 | 0 | 0 | -37 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.8m | 0.3% | 13 | 2.5 | 2.7 | 0 | 0 | 0 | -16 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.0% | 13 | 0.8 | 2.6 | 0 | 1 | 0 | -14 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.5m | 0.0% | 13 | 0.0 | 2.4 | 0 | 0 | 1 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.3m | 0.4% | 13 | 1.0 | 2.5 | 0 | 0 | 1 | -105 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.5% | 13 | 1.0 | 2.7 | 0 | 0 | 0 | 3 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.6m | 1.1% | 13 | 0.2 | 2.3 | 1 | 1 | 0 | 11 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.7m | 2.8% | 13 | 2.0 | 2.3 | 8 | 0 | 0 | 12 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.1m | 1.1% | 12 | 0.0 | 2.4 | 0 | 0 | 0 | -138 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.7m | 0.4% | 12 | 1.5 | 2.1 | 1 | 0 | 0 | -39 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.3m | 0.8% | 12 | 1.8 | 1.9 | 2 | 0 | 0 | -93 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.5m | 0.0% | 12 | 3.0 | 2.2 | 2 | 1 | 0 | -2 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.9m | 1.0% | 12 | 1.8 | 2.4 | 2 | 0 | 0 | -28 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.0m | 0.0% | 12 | 0.8 | 2.4 | 0 | 1 | 0 | 0 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.8% | 12 | 0.8 | 2.4 | 0 | 1 | 0 | -276 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.2m | 3.0% | 12 | 0.0 | 2.9 | 0 | 0 | 1 | -1,026 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.9m | 0.2% | 12 | 2.5 | 2.4 | 0 | 0 | 0 | -24 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £7.0m | 2.9% | 11 | 1.8 | 1.6 | 0 | 0 | 1 | -333 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.0m | 0.1% | 11 | 1.8 | 1.8 | 1 | 0 | 1 | -53 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.8m | 0.0% | 11 | 2.5 | 2.3 | 0 | 1 | 0 | -26 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.4m | 0.8% | 11 | 0.2 | 2.0 | 0 | 0 | 0 | -362 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 0.1% | 11 | 2.5 | 2.5 | 1 | 0 | 0 | 12 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.3m | 0.2% | 11 | 0.8 | 2.6 | 2 | 1 | 0 | 5 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.8m | 0.8% | 11 | 0.8 | 1.9 | 0 | 0 | 1 | -237 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £6.8m | 0.9% | 11 | 0.0 | 1.6 | 0 | 0 | 0 | -260 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.7m | 0.1% | 11 | 0.2 | 1.9 | 0 | 1 | 0 | -8 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £6.4m | 0.3% | 11 | 0.2 | 1.7 | 1 | 0 | 0 | -117 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.7% | 10 | 0.2 | 2.3 | 0 | 0 | 0 | -232 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.8m | 0.7% | 10 | 1.0 | 1.7 | 1 | 0 | 0 | -161 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.3m | 0.5% | 10 | 2.0 | 1.9 | 0 | 0 | 0 | -89 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.3m | 0.1% | 10 | 0.2 | 1.9 | 0 | 0 | 0 | -22 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.8m | 0.5% | 10 | 0.0 | 2.1 | 0 | 1 | 0 | -193 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.1% | 10 | 1.2 | 1.9 | 0 | 0 | 0 | -6 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £6.5m | 0.4% | 10 | 0.0 | 1.5 | 0 | 0 | 0 | -60 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £3.9m | 0.5% | 10 | 1.2 | 2.6 | 0 | 0 | 0 | 3 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.7m | 0.5% | 10 | 1.2 | 2.1 | 0 | 0 | 0 | -69 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.2m | 1.3% | 10 | 0.5 | 2.4 | 1 | 0 | 0 | -409 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.3m | 0.5% | 10 | 0.0 | 1.9 | 0 | 0 | 0 | -60 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.4m | 0.2% | 10 | 2.2 | 2.3 | 5 | 0 | 0 | 31 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.1% | 9 | 0.5 | 2.0 | 0 | 0 | 0 | -51 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 0.1% | 9 | 0.2 | 2.0 | 0 | 1 | 0 | -45 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.2m | 0.0% | 9 | 1.5 | 1.7 | 1 | 0 | 0 | -5 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.9m | 0.1% | 9 | 2.2 | 1.8 | 8 | 1 | 0 | 312 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.4m | 0.3% | 9 | 2.0 | 2.0 | 0 | 0 | 0 | -646 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.0m | 0.0% | 9 | 1.2 | 1.8 | 1 | 0 | 0 | 3 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.4m | 0.1% | 9 | 1.2 | 1.7 | 0 | 0 | 0 | -2 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.2m | 0.4% | 9 | 0.5 | 2.1 | 1 | 0 | 0 | -8 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.7m | 0.5% | 9 | 0.8 | 1.6 | 0 | 0 | 0 | -99 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.0m | 0.1% | 9 | 0.8 | 1.8 | 0 | 0 | 0 | -34 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.8m | 0.9% | 9 | -0.2 | 1.9 | 0 | 0 | 0 | -66 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.3m | 0.4% | 9 | 0.8 | 2.1 | 0 | 0 | 1 | -15 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.7m | 0.3% | 9 | 1.5 | 1.6 | 0 | 0 | 0 | -6 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.3m | 0.4% | 9 | 1.5 | 1.7 | 0 | 1 | 0 | 30 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.7m | 0.7% | 9 | 0.8 | 1.6 | 1 | 0 | 0 | -92 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.2m | 0.1% | 9 | 2.0 | 1.7 | 3 | 0 | 0 | -1 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.8m | 0.0% | 8 | 0.5 | 1.7 | 1 | 0 | 0 | -11 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.8m | 0.1% | 8 | 0.2 | 1.7 | 0 | 0 | 0 | -2 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.8m | 0.7% | 8 | 0.8 | 1.7 | 1 | 0 | 0 | -90 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.4m | 0.3% | 8 | 0.0 | 1.8 | 0 | 1 | 0 | -52 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.4m | 0.0% | 8 | 1.8 | 1.5 | 1 | 0 | 1 | -2 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.4m | 0.2% | 8 | 1.8 | 1.8 | 4 | 0 | 0 | 9 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.8m | 0.1% | 8 | 1.2 | 1.7 | 1 | 0 | 0 | -13 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.1% | 8 | 0.8 | 1.7 | 0 | 0 | 0 | -2 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.9m | 0.2% | 8 | 0.8 | 1.6 | 0 | 0 | 0 | -171 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £6.9m | 1.0% | 8 | 0.0 | 1.2 | 0 | 1 | 0 | -167 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.8m | 0.1% | 8 | 0.2 | 1.4 | 0 | 0 | 0 | -9 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £3.9m | 1.0% | 8 | 0.2 | 2.1 | 0 | 1 | 0 | -170 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.8m | 0.0% | 8 | 1.2 | 1.7 | 0 | 0 | 0 | -4 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.2m | 0.4% | 7 | 0.5 | 1.3 | 0 | 0 | 0 | -197 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.5m | 0.0% | 7 | 1.8 | 1.6 | 7 | 0 | 0 | 39 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £7.3m | 0.8% | 7 | 1.8 | 1.0 | 1 | 0 | 1 | 408 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.2m | 0.1% | 7 | 0.8 | 1.3 | 1 | 0 | 0 | -5 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.4m | 0.4% | 7 | 0.0 | 1.6 | 0 | 0 | 0 | -58 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.3m | 0.1% | 7 | 0.0 | 1.3 | 0 | 0 | 1 | -4 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.5m | 0.2% | 7 | 0.8 | 1.3 | 2 | 0 | 0 | -5 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.8m | 0.1% | 7 | 0.0 | 1.5 | 1 | 1 | 0 | -19 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.7m | 0.3% | 7 | 0.2 | 1.5 | 0 | 0 | 0 | -46 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.3m | 0.1% | 7 | 0.2 | 1.3 | 1 | 0 | 0 | -5 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.3m | 0.0% | 7 | 0.2 | 1.3 | 0 | 0 | 1 | 1 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.4m | 0.1% | 6 | 0.0 | 1.4 | 0 | 0 | 0 | -16 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £6.0m | 0.2% | 6 | 0.5 | 1.0 | 0 | 0 | 0 | 23 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.0m | 0.0% | 6 | 0.0 | 1.2 | 0 | 1 | 0 | -10 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.3m | 0.3% | 6 | 0.8 | 1.1 | 0 | 0 | 0 | -18 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 0.1% | 6 | 0.5 | 1.4 | 0 | 0 | 0 | -14 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.3m | 0.1% | 6 | 0.2 | 1.1 | 0 | 0 | 0 | -1 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.0% | 6 | 0.0 | 1.2 | 0 | 1 | 0 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.4m | 0.5% | 6 | 0.0 | 1.4 | 0 | 0 | 0 | -183 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.8m | 0.1% | 6 | 0.0 | 1.2 | 0 | 0 | 0 | -9 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.9m | 0.0% | 6 | 1.2 | 1.2 | 0 | 0 | 1 | -3 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.4m | 0.0% | 6 | 1.0 | 1.1 | 0 | 0 | 0 | 1 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.4m | 0.0% | 6 | 1.2 | 1.1 | 0 | 0 | 0 | -12 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.2m | 0.7% | 5 | 0.5 | 1.0 | 0 | 0 | 0 | -46 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.9m | 0.1% | 5 | 1.0 | 1.0 | 1 | 0 | 0 | -15 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.9m | 0.1% | 5 | 0.0 | 1.0 | 0 | 0 | 0 | 10 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.3m | 0.0% | 5 | 0.8 | 0.9 | 0 | 0 | 0 | 0 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.2m | 0.0% | 5 | 0.0 | 1.0 | 0 | 0 | 0 | -2 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.9m | 0.0% | 5 | 0.5 | 1.0 | 0 | 0 | 0 | -7 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.9m | 0.0% | 5 | 0.2 | 1.0 | 0 | 0 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.1% | 5 | 0.2 | 1.0 | 0 | 0 | 0 | -15 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 0.4% | 5 | 0.5 | 1.3 | 0 | 0 | 0 | 57 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 1.0% | 5 | 0.2 | 1.3 | 1 | 0 | 0 | -148 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.9m | 0.1% | 5 | 0.5 | 1.0 | 0 | 0 | 0 | -14 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.0% | 5 | 0.2 | 1.0 | 1 | 0 | 1 | 29 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 0.0% | 5 | 0.5 | 1.1 | 1 | 0 | 0 | 1 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.4m | 0.0% | 5 | 0.2 | 0.9 | 0 | 0 | 0 | -13 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £5.5m | 0.2% | 4 | 0.0 | 0.7 | 0 | 0 | 0 | -31 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.7m | 0.3% | 4 | 0.2 | 0.7 | 0 | 0 | 0 | -13 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 0.0% | 4 | 0.0 | 0.8 | 0 | 0 | 0 | -12 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.3m | 0.1% | 4 | 0.2 | 0.8 | 0 | 0 | 0 | -7 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £3.9m | 0.4% | 4 | 0.0 | 1.0 | 0 | 0 | 0 | -95 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.3m | 5.4% | 4 | 0.2 | 0.9 | 0 | 0 | 0 | -1,104 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.8m | 0.1% | 4 | 0.5 | 0.8 | 0 | 0 | 0 | -11 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.1m | 1.1% | 4 | 0.0 | 0.8 | 0 | 0 | 0 | -176 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.9m | 0.1% | 4 | 0.5 | 0.8 | 0 | 0 | 0 | -1 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.9m | 0.4% | 4 | 0.0 | 0.7 | 0 | 0 | 1 | -35 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £5.7m | 0.1% | 4 | 0.2 | 0.7 | 0 | 0 | 0 | -78 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.8m | 0.0% | 4 | 0.0 | 0.8 | 0 | 0 | 0 | -4 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.4m | 1.0% | 4 | 1.0 | 0.9 | 1 | 0 | 0 | -166 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.4m | 0.0% | 4 | 0.2 | 0.7 | 0 | 0 | 0 | -4 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £6.5m | 0.1% | 4 | 0.8 | 0.6 | 0 | 0 | 0 | -52 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.1% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -8 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.9m | 0.0% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | 2 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.2m | 3.1% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -622 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.3m | 0.0% | 3 | 0.2 | 0.6 | 1 | 0 | 0 | -3 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.2m | 0.0% | 3 | 0.2 | 0.7 | 0 | 0 | 0 | -4 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £6.3m | 1.1% | 3 | 0.0 | 0.5 | 0 | 0 | 0 | -223 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.3m | 0.2% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -30 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.5m | 0.0% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -8 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.7m | 0.6% | 3 | 0.5 | 0.6 | 0 | 0 | 0 | -39 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.2% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -14 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.4m | 0.0% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | 0 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.2m | 0.2% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -89 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.9m | 0.0% | 3 | 0.5 | 0.6 | 1 | 0 | 0 | 1 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.3m | 0.9% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -139 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.0% | 3 | 0.5 | 0.7 | 1 | 0 | 0 | 3 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.0% | 3 | 0.2 | 0.6 | 0 | 0 | 0 | -2 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.9m | 0.0% | 3 | 0.2 | 0.6 | 0 | 0 | 0 | 7 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £6.0m | 0.0% | 3 | 0.5 | 0.5 | 1 | 0 | 0 | -2 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.9m | 0.1% | 3 | 0.5 | 0.6 | 0 | 0 | 0 | 24 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.8m | 0.1% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -6 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.3m | 0.1% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -39 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.0% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -4 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.2m | 0.1% | 2 | 0.2 | 0.4 | 0 | 0 | 0 | -20 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.3m | 0.1% | 2 | 0.5 | 0.4 | 1 | 0 | 0 | -38 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 0.0% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -3 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.0m | 0.1% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | 7 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.4m | 0.1% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -4 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.9m | 0.5% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -80 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £6.2m | 0.5% | 2 | 0.0 | 0.3 | 0 | 0 | 0 | -82 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.9m | 0.0% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -2 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.4m | 0.4% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -58 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.0m | 0.0% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | -3 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 0.5% | 2 | 0.2 | 0.5 | 1 | 0 | 0 | -64 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.4m | 2.5% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | -1,165 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.3m | 0.2% | 2 | 0.2 | 0.5 | 0 | 0 | 0 | -29 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.4m | 0.1% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | -30 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.3m | 0.2% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | -61 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.9m | 0.5% | 2 | 0.0 | 0.3 | 0 | 0 | 0 | -43 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.8m | 0.0% | 2 | 0.2 | 0.4 | 0 | 0 | 0 | 1 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.1% | 1 | 0.2 | 0.2 | 1 | 0 | 0 | 203 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.5m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -7 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -8 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -39 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.4m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -41 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.4m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -47 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.8m | 0.0% | 1 | 0.2 | 0.2 | 0 | 0 | 0 | 20 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.8m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -2 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.9m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 32 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 7 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £3.9m | 0.1% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | 5 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £3.9m | 0.0% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | -10 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.3m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -1 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £3.9m | 0.1% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | 4 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 1.1% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | -230 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.7m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -4 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 1 | 0.2 | 0.2 | 0 | 0 | 0 | 0 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 1 | 0.2 | 0.2 | 0 | 0 | 0 | 3 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.3m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 4 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.4m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -4 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £3.9m | 0.2% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | 32 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.3m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -2 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -37 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.8m | 0.2% | 1 | 0.2 | 0.2 | 0 | 0 | 0 | -20 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.8m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 2 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -2 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.7% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -242 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.9m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 494 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £6.3m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £5.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -11 | MCI (H) BRE (A) TOT (A) BOU (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -333 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.4m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -81 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £7.8m | 2.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -128 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -16 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -69 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 6 | IPS (A) EVE (H) CRY (H) COV (A) | |
| £4.0m | 3.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -691 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -17 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -11 | FUL (A) BHA (H) HUL (H) ARS (A) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.4m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -187 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 5 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -19 | MUN (A) ARS (H) MCI (H) FUL (A) | |
| £3.9m | 3.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -618 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.4m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -27 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | NEW (H) BOU (A) NFO (A) EVE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -25 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -60 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -20 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | NFO (A) CRY (H) LIV (H) MCI (A) | |
| £4.0m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -165 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.4m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -27 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -30 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £3.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -17 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.4m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -35 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -30 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.3m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.0m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -140 | LEE (A) IPS (H) MUN (A) AVL (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.7m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -14 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.0m | 1.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -199 | HUL (H) CHE (A) AVL (A) MUN (H) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 4 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -21 | LIV (H) AVL (A) FUL (H) BHA (A) | |
| £4.0m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -371 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -18 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.3m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -209 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.3m | 4.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1,154 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -11 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.4m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -123 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BOU (H) TOT (A) EVE (A) BRE (H) | |
| £4.0m | 1.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -152 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £3.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -33 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.3m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 19 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 4 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -11 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -37 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | CRY (A) NFO (H) BOU (A) TOT (H) | |
| £4.0m | 3.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -668 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.0m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -86 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £3.9m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -94 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.7m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | AVL (H) COV (A) LEE (A) NEW (H) | |
| £4.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -39 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -14 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -14 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -37 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.0m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -165 | COV (H) MCI (A) IPS (H) LIV (A) | |
| £4.8m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -162 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -28 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £3.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £3.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -14 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.8m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.3m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 31 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £7.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -73 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | EVE (A) SUN (H) CHE (A) LEE (H) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.1m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -52 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £6.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | ARS (A) LEE (H) BRE (A) CHE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 8 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £3.9m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 12 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.4m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -27 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.3m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 157 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.5m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -192 | BRE (H) NEW (A) COV (H) CRY (A) | |
| £4.8m | 0.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -67 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -82 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -24 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -68 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | BHA (A) MUN (H) SUN (H) IPS (A) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £3.9m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 4 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -10 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | CHE (H) HUL (A) BHA (H) SUN (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -21 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -196 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £3.9m | 15.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2,998 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -18 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.4m | 0.8% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -169 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.5m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -202 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 11 | SUN (A) FUL (H) ARS (H) HUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -16 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -16 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | TOT (H) LIV (A) NEW (A) NFO (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | TOT (H) LIV (A) NEW (A) NFO (H) |